Biotech incubator Proto Axiom banks $20 million towards $30m Series B
Biomedical technology incubator Proto Axiom has raised $20 million in the first close of a planned $30m Series B. The company did not name its latest backers, who join the likes of Catalio, Parkview International, Churchill Asset Management and HOF Capital, who invested in a $15m Series A in September 2022.’ Proto Axiom set out… Read more »